non-invasive mechanical ventilation – Communicable Diseases Research

Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves

델타 및 오미크론 파동 동안 예방 접종을 받지 않은 임신에서 SARS-CoV-2 감염의 산모 및 주산기 결과

Article

Published on 2022-07-012022-09-11
Journal: Ultrasound in obstetrics & gynecology : the offici
[Category] COVID19(2023년), SARS, 변종,

Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure

Article

Published on 2022-03-242022-10-05
Journal: Critical Care
[Category] 임상,

[키워드] Acute respiratory failure Admission Alter ARF cannula changes in clinical Clinical outcome Clinical practice cohort of patient consecutive patient correlated correlation COVID-19 de novo endotracheal Endotracheal intubation enrolled Escalation Esophageal pressure swings feature insertion Inspiratory effort intensive care unit Italy limit Lung injury magnitude measure Mechanical Modena nasal Nasal pressure swings non-invasive mechanical ventilation Non-invasive respiratory support non-invasive ventilation Patient Primary outcome R 2 remained required respiratory Respiratory failure Respiratory mechanics respiratory monitoring respiratory rate Self-Inflicted Lung Injury Self-inflicted lung injury. significantly splitting study population swing translate university were recorded worsening
[DOI] 10.1186/s13054-022-03938-w PMC 바로가기 [Article Type] Article

Predictor factors for non-invasive mechanical ventilation failure in severe COVID-19 patients in the intensive care unit: a single-center retrospective study

Original Article

Published on 2022-02-152022-10-30
Journal: Journal of Anesthesia, Analgesia and Critical Care
[Category] COVID-19,

[키워드] adjusted admitted to ICU anonymously applied ARDS Charlson Comorbidity Index collected COVID-19 Cox regression analysis CPK critical COVID-19 patient demographic Endotracheal intubation Factor ICU ICU admission INR intensive care intensive care unit Laboratory laboratory feature mechanical ventilation median median value medical record NIV Non-invasive non-invasive mechanical ventilation non-invasive ventilation outcome Pandemia PaO predict Predictive predictive factor predictor Result retrospective Retrospective study risk severe COVID-19 severe COVID-19 patient single-center supplementary material supported variable was performed
[DOI] 10.1186/s44158-022-00038-7 PMC 바로가기 [Article Type] Original Article

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers

염증 표지자를 기반으로 한 COVID-19에서의 코르티코스테로이드 또는 토실리주맙의 사용

Article

Published on 2022-01-012022-09-11
Journal: Journal of General Internal Medicine
[Category] SARS, 바이오마커, 진단,

[키워드] administer Admission C-reactive protein cause of death collected Combination Corticosteroids COVID-19 COVID-19 patients CRP D-dimer values death in COVID-19 Efficacy Escalation evaluate ferritin HFNC high risk High-flow nasal cannula Hospital mortality ICU IMV in-hospital mortality inclusion criteria Inflammation inflammatory cascade intensive care intensive care unit Invasive mechanical ventilation Lactate lactate dehydrogenase LDH lower mortality lymphocyte Lymphocyte count mechanical ventilation Mortality nasal nasal cannula NIMV no significant differences Non-invasive non-invasive mechanical ventilation outcome Patient patients prescription Primary outcome propensity score matching registry retrospective cohort study Risk category secondary Secondary outcomes significant difference Spanish statistically significant TCZ therapy Tocilizumab treat treated Treatment Treatment.
[DOI] 10.1007/s11606-021-07146-0 PMC 바로가기 [Article Type] Article

Evaluation of eye care and ocular findings in critically ill COVID-19 patients

중환자 COVID-19 환자의 안과 진료 및 안과 소견 평가

Article

Published on 2021-12-012022-09-11
Journal: International journal of clinical practice
[Category] SARS, 치료기술,

[키워드] addition age Care chemosis condition conjunctivitis Corneal abrasion COVID-19 infection COVID-19 patient Critically ill disease eight evaluate exposure keratopathy eye care finding Follow-up in viral indirect ophthalmoscope Infection infections initiated intensive care intensive care unit intensive care units Invasive mechanical ventilation keratitis keratopathy knowledge material mechanical ventilation men moderate Non-invasive non-invasive mechanical ventilation ocular one patient Patient patient age patients patients treated performed retinal haemorrhage secondary to Seven Support supported systemic disease systemic diseases the disease the patient treated Treatment viral infections vision women
[DOI] 10.1111/ijcp.14909 PMC 바로가기 [Article Type] Article

Evaluation of the effect of clinical characteristics and intensive care treatment methods on the mortality of covid-19 patients aged 80 years and older

80 세 이상의 COVID-19 환자의 사망률에 대한 임상 특성 및 집중 치료 치료 방법의 영향 평가

Research

Published on 2021-11-222022-09-10
Journal: BMC Anesthesiology
[Category] MERS, SARS, 치료기술,

[키워드] age albumin anti-cytokine Clinical characteristics Clinical features comorbid diseases Computed tomography coronavirus disease Coronavirus disease 2019 COVID-19 pandemic COVID-19 patients CRP Cytokines Effect ferritin Gender hemodiafiltration HFNC High flow nasal cannula ICU treatment IMV Increased increased risk intensive care intensive care treatment intensive care unit Invasive mechanical ventilation investigated Laboratory laboratory findings LDH mean value mechanical ventilation Mortality mortality rate nasal nasal cannula NIMV Non-invasive non-invasive mechanical ventilation non-survivor Older older adult Older adults outcome pandemic Patient PCT plasma plasma therapy Result significantly significantly higher statistically survivor the patient therapy Thoracic Topic treated Treatment two group two groups were assessed
[DOI] 10.1186/s12871-021-01511-6 PMC 바로가기 [Article Type] Research

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

치료 헤파린 대 예방 헤파린이 병원에 입원한 중등도의 코로나19 환자에서 사망, 기계적 환기 또는 중환자실 입원에 대한 효과: RAPID 무작위 임상 시험

Randomized Controlled Trial

Published on 2021-10-142022-09-11
Journal: The BMJ
[Category] MERS, SARS, 바이오마커, 임상, 진단,

[키워드] 95% confidence interval adaptive Admission age assigned bleeding body mass body mass index Brazil Canada clinical trial Composite D-dimer level death dose evaluate the effect heparin hospital hospital discharge hospital ward Hospital wards ill patient intensive care intensive care unit Invasive mechanical ventilation Ireland low molecular weight Major major bleeding mechanical ventilation men Non-invasive non-invasive mechanical ventilation occurred Odds ratio open open label outcome participant Patient Primary outcome Prophylactic prophylactic dose randomised Randomly recruited reduction in risk Safety Saudi Arabia secondary outcome Secondary outcomes significantly the mean therapeutic therapeutic dose Thromboembolism Trial two patients unfractionated heparin United Arab Emirates Venous Thromboembolism
[DOI] 10.1136/bmj.n2400 PMC 바로가기 [Article Type] Randomized Controlled Trial

Remdesivir for the treatment of COVID-19

코로나19 치료제 렘데시비르

Article

Published on 2021-08-052022-09-11
Journal: The Cochrane database of systematic reviews
[Category] SARS, 임상, 치료제,

[키워드] 95% CI 95% confidence interval adverse event adverse events age all-cause mortality antiviral medicine approach authorisation baseline CENTRAL certainty certainty of evidence chance citation clinical Clinical improvement Clinical outcome clinical outcomes clinical status Cochrane COVID-19 Study Register comparable conducted contribute Controlled controlled trials coronavirus disease coronavirus diseases COVID-19 COVID-19 patient COVID-19 patients COVID-19 research Data collection decrease defined diagnosed died disease severity Effect Efficacy and safety Emergency use Ethnicity evaluated Evidence excluded FIVE Future Gender high risk High-flow oxygen hospitalised hospitalised patient Hospitalised patients identify increase index individual information inhibit initial Invasive mechanical ventilation lack liberation life low-flow oxygen maintain Mask mechanical ventilation media medRxiv methodology Missing data missing value missing values Mortality MOST nasal prong nasal prongs need for oxygen no difference no effect Non-invasive non-invasive mechanical ventilation non-invasive ventilation observation outcome outcomes oxygen participant Participants Patient Placebo potential benefit potential benefits Quality of life randomised randomised controlled trial Randomised controlled trials RCT RCTs receive recruit registry Remdesivir reported required Respiratory Support risk risk difference risk of bia risk ratio RoB 2 SARS-CoV-2 SARS-COV-2 infection Science Citation Index searched Selection Serious Adverse Event Serious Adverse Events severity Source standard care subgroup subgroups supplemental oxygen systematic review Treatment viral replication Web of Science WHO WHO International Clinical Trials Registry Platform worsening
[DOI] 10.1002/14651858.CD014962 PMC 바로가기 [Article Type] Article

COVID-19 in Turkey: A tertiary center experience

터키의 COVID-19: 3차 센터 경험

Article

Published on 2021-07-012022-09-11
Journal: Pediatrics international : official journal of the
[Category] SARS, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus addition Adult patients Azithromycin caused children children. clinical feature Combination Comorbidities Contact contact with coronavirus disease Coronavirus-2 country COVID-19 COVID-19 infection Critical D-dimer value diagnosed with COVID-19 disease Epidemic epidemiological Health health problem healthy Hydroxychloroquine Infection Invasive mechanical ventilation Laboratory lymphocyte Lymphocytes male median age Medical conditions Mild mild infection moderate non-invasive mechanical ventilation oseltamivir Patient radiological finding required SARS-CoV-2 SARS-CoV-2 virus Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 severe or critical illness the SARS-CoV-2 virus was used
[DOI] 10.1111/ped.14549 PMC 바로가기 [Article Type] Article

A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial

SARS-CoV-2 유발 급성 호흡곤란 증후군에 대한 정맥내 혈장 정제 알파-1 항트립신의 무작위 이중 맹검 위약 대조 파일럿 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2021-04-192022-09-10
Journal: Trials
[Category] 임상,

[키워드] 24 hours active malignancy acute kidney Acute kidney injury acute respiratory distress syndrome addition Administered administration adverse event adverse events AEs age Alpha alpha-1 antitrypsin Amendment Anti-viral Antibiotics anticipated antitrypsin antivirals approval approved ARDS ARMS authority bacterial pneumonia baseline Berlin criteria blinded to treatment Blinding BMI body weight Cancer changes in Child-Pugh score chloride Chronic kidney disease chronic liver disease circulating class clinical Clinical outcome clinical trial Combination commenced Committee comparator Complete conducted Consent Controlled trial correction COVID-19 Culture cytokine level cytokine levels Data collection defined determine Diagnosis diagnosis of ARDS dialysis dissemination DNAR double-blind Echocardiogram Effect Effectiveness elapsed element ELISA enrolled EudraCT excluded exclusion exclusion criteria facilitate Follow-up followed by for inclusion group Health Products regulatory Authority hospital Hospital admission hypertension ICU IgA deficiency IL-10 IL-1β IL-6 IL-8 incidence inclusion criteria individual information intensive care unit intensive care units interim analysis interleukin interleukin-10 interleukin-1β interleukin-6 interleukin-8 interpreter Intervention intravenous intravenous infusion intravenously invasive investigational medicinal product investigator Ireland Kidney disease Laboratory laboratory-confirmed life Local maintain major trauma malignancy mandatory marker mechanical ventilation Microscopy moderate moderate to severe Mortality Non-invasive non-invasive mechanical ventilation non-invasive ventilation number objective occur Organ failure outcome outcome measure PaO participant Patient patient recruitment patients with moderate PCR-confirmed Phase 2 physician Placebo placebo-controlled plasma plasma analysis plasma concentration plasma concentrations pregnant preparation product protocol provided Pulmonary embolism pulmonary hypertension purified Radiographic randomisation randomisation list randomised randomised controlled trial rationale readmission REC receiving receptor recruited recruitment reduce Regulatory removal renal renal replacement therapy replacement therapy reported required Research Research Ethics Research Ethics Committee research nurse research nurses respiratory respiratory distress Respiratory distress syndrome resulting Resuscitation SAE SAEs Sample size SARS-CoV-2 secondary secondary bacterial pneumonia Secondary objective Secondary objectives Secondary outcomes secretion Sequential Organ Failure Assessment Serious Adverse Event Serious Adverse Events severe ARDS Shock single dose skin cancer Sodium chloride SOFA Standard statistician stratified study participation Study protocol subject submitted supplementary material Support sustained TNF TNF-α Tolerability trauma Treatment treatment allocation Trial trial protocol Trial registration vasopressors ventilator verbal Version Volume website WHO Withdrawal writing
[DOI] 10.1186/s13063-021-05254-0 PMC 바로가기 [Article Type] Letter